Do Aspirin and Clopidogrel Follow the Same Road Toward Prevention of Colorectal Cancer?

Manol Jovani; Andrew T. Chan

doi:10.1016/j.cgh.2019.02.033

Do Aspirin and Clopidogrel Follow the Same Road Toward Prevention of Colorectal Cancer?

Manol Jovani, Andrew T. Chan

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	1945-1947
Number of pages	3
Journal	Clinical Gastroenterology and Hepatology
Volume	17
Issue number	10
DOIs	https://doi.org/10.1016/j.cgh.2019.02.033
State	Published - Sep 2019
Externally published	Yes

Access to Document

10.1016/j.cgh.2019.02.033

Cite this

@article{06c6eb93973448a2a79fca66fb0031d9,

title = "Do Aspirin and Clopidogrel Follow the Same Road Toward Prevention of Colorectal Cancer?",

author = "Manol Jovani and Chan, {Andrew T.}",

note = "Funding Information: Conflicts of interest This author discloses the following: A.T.C. is a member of the Scientific Advisory Board of the International Aspirin Foundation and the steering committee for the Council on Aspirin for Health and Prevention. He receives support in part through Aspirin for Cancer Prevention Collaborative (AsCaP), an investigator-initiated Cancer Research UK Catalyst Award. He has previously received consulting fees from Bayer Pharma AG, Janssen Inc, and Pfizer Inc and a research grant from the Council on Aspirin for Health and Prevention and Bayer Pharma AG for unrelated preclinical studies. The remaining author discloses no conflicts.",

year = "2019",

month = sep,

doi = "10.1016/j.cgh.2019.02.033",

language = "English",

volume = "17",

pages = "1945--1947",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",